Comparison between JRG Securities IPO and Plethico Pharmaceuticals IPO.
JRG Securities IPO is a Mainboard Bookbuilding IPO proposed to list at BSE while Plethico Pharmaceuticals IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
| JRG Securities IPO | Plethico Pharmaceuticals IPO | |
|---|---|---|
| Logo |  | |
| Issue Category | Mainboard | Mainboard |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE | BSE, NSE |
| Lead Managers | Keynote Financial Services Ltd. | |
| Registrar | Bigshare Services Pvt.Ltd. | |
| Market Maker | ||
| DRHP | ||
| RHP | ||
| Final Prospectus | Final Prospectus  | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of JRG Securities IPO is up to ₹14.50 Cr whereas the issue size of the Plethico Pharmaceuticals IPO is up to ₹110.00 Cr. The final issue price of JRG Securities IPO is ₹40.00 per share and of Plethico Pharmaceuticals IPO is ₹300.00 per share.
| JRG Securities IPO | Plethico Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹280.00 per share | |
| Issue Price (Upper) | ₹300.00 per share | |
| Issue Price (Final) | ₹40.00 per share | ₹300.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 36,25,000 shares | 36,66,667 shares |
| Fresh Issue Size (Amount) | up to ₹14.50 Cr | up to ₹110.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 36,25,000 shares | 36,66,667 shares |
| Issue Size Total (Amount) | up to ₹14.50 Cr | up to ₹110.00 Cr |
JRG Securities IPO opens on Apr 17, 2006, while Plethico Pharmaceuticals IPO opens on Apr 10, 2006. The closing date of JRG Securities IPO and Plethico Pharmaceuticals IPO is Apr 21, 2006, and Apr 17, 2006, respectively.
JRG Securities IPO P/E ratio is 24.78, as compared to Plethico Pharmaceuticals IPO P/E ratio of .
| JRG Securities IPO | Plethico Pharmaceuticals IPO | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| |||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 97.5 | ||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 71.66 | 87.01 | ||||||||||||||||||||
| P/E Ratio | 24.78 | |||||||||||||||||||||
| Market Cap | ₹51.16 Cr. | ₹1022.00 Cr. | ||||||||||||||||||||
| ROE | ||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||
| EPS | ₹1.61 | |||||||||||||||||||||
| RoNW | 40.78 | |||||||||||||||||||||
In the JRG Securities IPO Retail Individual Investors (RII) are offered 15,98,750 shares while in Plethico Pharmaceuticals IPO retail investors are offered 15,98,750 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in JRG Securities IPO and 22,00,000 shares in Plethico Pharmaceuticals IPO.
| JRG Securities IPO | Plethico Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 22,00,000 shares |
| NII | 15,98,750 shares | 3,66,667 shares |
| RII | 15,98,750 shares | 11,00,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 36,25,000 shares | 36,66,667 shares |
JRG Securities IPO subscribed in total, whereas Plethico Pharmaceuticals IPO subscribed .
